Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
14.13Price to Earnings
VS
Market
Sector
Industry
History
$ 34.65Close
$ 5.9 - $ 35.6 52-Week Range
Ticker Information
Ticker
STOKCompany Name
STOKE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSTOKE THERAPEUTICS INC - Price to Earnings Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
STOK - P/E Historical data
| Date | Market Capitalization | Net Income Common Stock | Price to Earnings |
|---|---|---|---|
| 6/30/2025 | $ 741.41M | $ 52.48M | 14.13 |
| 3/31/2025 | $ 487.55M | $ 50.27M | 9.7 |
| 12/31/2024 | $ 479.67M | $ -88.98M | 0 |
| 9/30/2024 | $ 691.22M | $ -105.46M | 0 |
| 6/30/2024 | $ 721.8M | $ -103.57M | 0 |
| 3/31/2024 | $ 618.66M | $ -108.53M | 0 |
| 12/31/2023 | $ 300.97M | $ -104.7M | 0 |
| 9/30/2023 | $ 216.57M | $ -103.4M | 0 |
| 6/30/2023 | $ 258.9M | $ -104.97M | 0 |
| 3/31/2023 | $ 473.7M | $ -98.96M | 0 |
Key Performance Insights, Last 5 Years
- STOKE THERAPEUTICS INC's latest trailing twelve months (TTM) P/E stands at 0.
- Over the past 5 years, STOKE THERAPEUTICS INC's average P/E has been 11.91.
- The median P/E for STOKE THERAPEUTICS INC during this period was 11.91
- STOKE THERAPEUTICS INC reached its highest P/E over the past 5 years at 14.13.
- The lowest P/E recorded by STOKE THERAPEUTICS INC in the same timeframe 9.7
STOKE THERAPEUTICS INC's P/E vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/E Benchmarks
Similar metrics to P/E:
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Price to Earnings
[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.Market Cap / Net Inc. Cmn.
(=) P/E P/E for STOKE THERAPEUTICS INC is calculated as follows: Market Cap [ $ 1.48B ] / Net Inc. Cmn. [ $ -47.84M ]
(=) P/E [ 0 ] STOK - Price to Earnings, Last 5 years
9.7
Minimum
Mar 31, 2025
14.13
Maximum
Jun 30, 2025
11.91
Average
11.91
Median
P/E Benchmark AnalysisMarket
The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.54 with a standard deviation of 14.
The following table provides additional summary stats:
P/E in the Market:
| filtered constituents | 2.08K |
|---|---|
| min | 0.13 |
| max | 70.48 |
| average | 22.54 |
| median | 18.89 |
| std | 14 |